Caribou Biosciences, Inc.
A Contract Statistical Programmer at Caribou Biosciences supports clinical trials by creating CDISC data sets, tables, figures, and listings for reports and regulatory submissions. The role involves statistical programming, ad-hoc analysis, and quality control in a fast-paced environment.
Headquarters
Berkeley, California, United States
Company Size
51-200 employees
Founded
2012
Caribou Biosciences is a clinical-stage biopharmaceutical company developing genome-edited allogeneic (off‑the‑shelf) cell therapies for serious human diseases. The company leverages a next‑generation CRISPR platform and its patented chRDNA (CRISPR hybrid RNA‑DNA) technology to enable precise, multiplex genome edits while preserving genomic integrity. Caribou is advancing off‑the‑shelf CAR‑T programs for hematologic malignancies and uses “armoring” strategies (e.g., checkpoint disruption and immune cloaking) to enhance therapeutic activity. Leadership includes co‑founder and Nobel laureate Jennifer Doudna, and the company is progressing a clinical pipeline while recruiting talent.
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3 days ago
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
4 days ago
Caribou Biosciences to Participate in Upcoming Investor Conferences
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Caribou Biosciences, Inc..
65% below the average for this role
CRISPR-focused Caribou set for fireside chats at 2 investor events
3 weeks ago